AMWL
American Well Corporation NYSE Listed Sep 17, 2020$7.74
Mkt Cap $129.3M
52w Low $3.71
74.1% of range
52w High $9.15
50d MA $5.75
200d MA $5.63
P/E (TTM)
-1.0x
EV/EBITDA
1.4x
P/B
0.4x
Debt/Equity
0.0x
ROE
-40.6%
P/FCF
-1.2x
RSI (14)
—
ATR (14)
—
Beta
1.39
50d MA
$5.75
200d MA
$5.63
Avg Volume
88.3K
American Well Corporation operates as a telehealth software company that enables digital delivery of care for healthcare. The company products offer urgent care; scheduled visits; acute behavioral health; telestroke; pediatrics; retail health, school health, and home settings. Its application offers urgent care; pediatrics; therapy; menopause nutrition; end-stage renal disease and dialysis; dermatology care; behavioral health therapy; and musculoskeletal care. The company also provides telemedicine equipment, including telemedicine carts, peripherals, tyto care, TV kits, tablets, and kiosks. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.
75 State Street · Boston, MA 02109 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 5, 2026 | AMC | -0.77 | -0.66 | +14.3% | 6.36 | +16.5% | +12.4% | +21.9% | — | — | — | — |
| Feb 12, 2026 | AMC | -1.59 | -1.43 | +10.1% | 4.33 | +5.1% | +24.7% | +27.7% | +34.9% | +32.6% | +25.9% | — |
| Nov 4, 2025 | AMC | -1.46 | -1.74 | -19.4% | 5.05 | -0.8% | -9.5% | -19.0% | -16.6% | -20.0% | -22.8% | — |
| Aug 5, 2025 | AMC | -1.84 | -1.24 | +32.6% | 8.48 | -10.3% | -7.3% | -13.2% | -14.2% | -15.4% | -16.7% | — |
| May 1, 2025 | AMC | -3.09 | -1.73 | +44.0% | 6.19 | +24.7% | +19.7% | +18.1% | +9.7% | +9.5% | +12.4% | — |
| Feb 12, 2025 | AMC | -3.04 | -2.77 | +8.9% | 12.35 | -9.5% | -5.0% | -1.5% | -3.6% | +1.1% | -2.3% | — |
| Oct 30, 2024 | AMC | -3.32 | -2.87 | +13.6% | 9.65 | -6.7% | -5.1% | -6.7% | -5.5% | -7.7% | -7.7% | — |
| Jul 31, 2024 | AMC | -3.94 | -3.36 | +14.7% | 8.01 | +6.5% | +40.2% | +38.0% | +19.4% | +5.2% | -0.9% | — |
| May 1, 2024 | AMC | -3.60 | -5.00 | -38.9% | 10.62 | -6.8% | -2.0% | +7.3% | +7.1% | +4.7% | -2.4% | — |
| Feb 14, 2024 | AMC | -3.80 | -3.40 | +10.5% | 22.20 | +10.8% | +18.0% | +15.3% | +13.5% | +3.6% | -2.7% | — |
| Nov 1, 2023 | AMC | -4.00 | -4.00 | +0.0% | 23.60 | -6.8% | +13.6% | +20.3% | +3.4% | +5.9% | +4.2% | — |
| Aug 2, 2023 | AMC | -4.20 | -4.60 | -9.5% | 44.40 | -11.7% | -5.0% | -7.7% | -10.8% | -15.8% | -21.2% | — |
| May 3, 2023 | AMC | -4.00 | -4.80 | -20.0% | 42.40 | -5.7% | -6.1% | -2.4% | -5.2% | -5.2% | +0.0% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 13 | Stifel | Maintains | Hold → Hold | — | $4.33 | $4.55 | +5.1% | +24.7% | +27.7% | +34.9% | +32.6% | +25.9% |
| Dec 18 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $4.70 | $4.71 | +0.2% | +0.6% | -0.9% | -5.3% | -3.0% | -2.3% |
| Nov 5 | Wells Fargo | Maintains | Overweight → Overweight | — | $5.05 | $5.01 | -0.8% | -9.5% | -19.0% | -16.6% | -20.0% | -22.8% |
| Nov 5 | Stifel | Maintains | Hold → Hold | — | $5.05 | $5.01 | -0.8% | -9.5% | -19.0% | -16.6% | -20.0% | -22.8% |
| Aug 7 | Wells Fargo | Maintains | Overweight → Overweight | — | $7.86 | $7.90 | +0.5% | -6.4% | -7.4% | -8.8% | -10.2% | -8.5% |
| May 23 | Piper Sandler | Maintains | Neutral → Neutral | — | $7.40 | $7.30 | -1.4% | +0.3% | -5.5% | -5.5% | -6.6% | -8.9% |
| May 8 | UBS | Maintains | Neutral → Neutral | — | $6.78 | $6.78 | +0.0% | +2.7% | +0.9% | +6.3% | +12.1% | +5.2% |
| May 2 | Needham | Maintains | Hold → Hold | — | $6.19 | $7.72 | +24.7% | +19.7% | +18.1% | +9.7% | +9.5% | +12.4% |
| May 2 | Stifel | Maintains | Hold → Hold | — | $6.19 | $7.72 | +24.7% | +19.7% | +18.1% | +9.7% | +9.5% | +12.4% |
| Apr 10 | Truist | Maintains | Hold → Hold | — | $7.17 | $6.96 | -2.9% | +1.1% | -1.5% | +0.1% | -0.8% | -2.1% |
| Feb 14 | Truist | Maintains | Hold → Hold | — | $11.73 | $11.85 | +1.0% | +3.7% | +1.4% | +6.5% | +2.8% | +0.1% |
| Feb 13 | Needham | Maintains | Hold → Hold | — | $12.35 | $11.18 | -9.5% | -5.0% | -1.5% | -3.6% | +1.1% | -2.3% |
| Feb 13 | Stifel | Maintains | Hold → Hold | — | $12.35 | $11.18 | -9.5% | -5.0% | -1.5% | -3.6% | +1.1% | -2.3% |
| Jan 13 | Wells Fargo | Upgrade | Equal Weight → Overweight | — | $7.22 | $7.59 | +5.1% | +18.8% | +10.5% | +16.8% | +33.0% | +32.3% |
| Dec 17 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $8.73 | $8.58 | -1.7% | -3.2% | -10.0% | -10.2% | -9.9% | -14.8% |
| Aug 6 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $9.56 | $9.67 | +1.2% | -11.8% | -16.9% | -13.8% | -11.7% | -11.7% |
| May 23 | UBS | Maintains | Neutral → Neutral | — | $9.92 | $9.64 | -2.8% | -7.9% | -12.9% | -13.3% | -16.5% | -19.0% |
| Apr 15 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $11.51 | $11.91 | +3.5% | -3.1% | -10.4% | -10.7% | -10.0% | -5.0% |
| Nov 2 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $23.60 | $22.00 | -6.8% | +13.6% | +20.3% | +3.4% | +5.9% | +4.2% |
| Aug 3 | Morgan Stanley | Downgrade | Overweight → Equal Weight | — | $44.40 | $39.20 | -11.7% | -5.0% | -7.7% | -10.8% | -15.8% | -21.2% |
| May 4 | Credit Suisse | Maintains | Neutral → Neutral | — | $42.40 | $40.00 | -5.7% | -6.1% | -2.4% | -5.2% | -5.2% | +0.0% |
| Mar 23 | TD Cowen | Downgrade | Outperform → Market Perform | — | $46.60 | $44.00 | -5.6% | -3.9% | -3.4% | +0.4% | -3.4% | +0.0% |
| Mar 15 | Guggenheim | Maintains | Buy → Buy | — | $49.80 | $48.40 | -2.8% | -1.2% | +0.4% | -4.4% | -5.6% | -1.6% |
| Mar 13 | Morgan Stanley | Maintains | Overweight → Overweight | — | $47.00 | $46.00 | -2.1% | +4.7% | +6.0% | +4.7% | +6.4% | +1.3% |
| Feb 27 | Piper Sandler | Downgrade | Overweight → Neutral | — | $60.60 | $58.60 | -3.3% | -4.3% | -7.9% | -8.9% | -10.2% | -7.3% |
| Feb 23 | Needham | Maintains | Hold → Hold | — | $72.40 | $65.00 | -10.2% | -13.8% | -16.3% | -19.9% | -22.9% | -23.8% |
| Feb 23 | Credit Suisse | Maintains | Neutral → Neutral | — | $72.40 | $65.00 | -10.2% | -13.8% | -16.3% | -19.9% | -22.9% | -23.8% |
| Jan 6 | Morgan Stanley | Maintains | Overweight → Overweight | — | $64.80 | $65.60 | +1.2% | +2.8% | +4.3% | +7.7% | +12.3% | +18.5% |
| Jan 4 | BofA Securities | Upgrade | Neutral → Buy | — | $56.40 | $60.00 | +6.4% | +17.4% | +14.9% | +18.1% | +19.9% | +23.8% |
| Sep 7 | Truist | Maintains | Hold → Hold | — | $86.60 | $83.40 | -3.7% | -6.5% | +0.9% | +0.0% | -1.8% | -6.9% |
| Sep 7 | Piper Sandler | Maintains | Overweight → Overweight | — | $86.60 | $83.40 | -3.7% | -6.5% | +0.9% | +0.0% | -1.8% | -6.9% |
| Jun 23 | Piper Sandler | Maintains | Overweight → Overweight | — | $90.20 | $91.20 | +1.1% | +15.5% | +8.6% | +10.4% | +2.4% | -0.9% |
| May 17 | Piper Sandler | Maintains | Overweight → Overweight | — | $61.80 | $62.80 | +1.6% | +1.9% | -2.6% | -2.3% | -1.3% | +3.2% |
| May 10 | Morgan Stanley | Maintains | Overweight → Overweight | — | $54.60 | $54.00 | -1.1% | -3.7% | -4.4% | +4.4% | +17.6% | +13.2% |
| Feb 28 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $83.00 | $82.20 | -1.0% | +1.9% | -5.8% | -7.2% | -8.9% | -11.3% |
| Dec 17 | Morgan Stanley | Maintains | Overweight → Overweight | — | $117.00 | $117.00 | +0.0% | +9.9% | +4.3% | +9.4% | +7.7% | +9.9% |
| Dec 2 | Jefferies | Maintains | Hold → Hold | — | $124.40 | $123.00 | -1.1% | +2.3% | -2.3% | +1.1% | +5.9% | +8.8% |
| Nov 11 | Credit Suisse | Maintains | Neutral → Neutral | — | $175.00 | $162.00 | -7.4% | -6.2% | -1.0% | -2.4% | -7.3% | -9.4% |
| Sep 14 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $210.80 | $213.80 | +1.4% | -1.8% | -0.8% | +1.5% | +6.7% | -0.2% |
| Aug 31 | Morgan Stanley | Maintains | Overweight → Overweight | — | $211.20 | $210.00 | -0.6% | +1.4% | +0.3% | +2.0% | +0.8% | +1.3% |
| Aug 24 | Cowen & Co. | Maintains | Outperform → Outperform | — | $197.80 | $200.80 | +1.5% | +4.8% | +4.2% | +0.9% | +6.3% | +6.8% |
| Aug 12 | Credit Suisse | Maintains | Neutral → Neutral | — | $205.60 | $202.60 | -1.5% | +4.6% | +8.6% | +2.1% | +1.6% | -1.6% |
| Jul 2 | Morgan Stanley | Maintains | Overweight → Overweight | — | $252.40 | $250.20 | -0.9% | -2.7% | -3.6% | -4.0% | -3.2% | -3.8% |
| May 17 | Guggenheim | Upgrade | Neutral → Buy | — | $234.20 | $238.80 | +2.0% | +2.3% | +6.9% | +0.7% | +1.5% | -0.1% |
| May 13 | Credit Suisse | Maintains | Neutral → Neutral | — | $256.40 | $239.50 | -6.6% | -21.6% | -8.7% | -6.6% | -2.3% | -8.0% |
| Apr 16 | KeyBanc Capital Markets | Maintains | Sector Weight → Equal Weight | — | $347.20 | $342.40 | -1.4% | -2.1% | -3.2% | -3.7% | -0.3% | +3.4% |
| Apr 15 | Needham | Maintains | Hold → Hold | — | $344.60 | $342.40 | -0.6% | +0.8% | -1.3% | -2.4% | -3.0% | +0.5% |
| Mar 26 | Morgan Stanley | Maintains | Overweight → Overweight | — | $364.80 | $366.00 | +0.3% | -2.7% | -7.0% | -7.1% | -4.8% | -1.3% |
| Jan 28 | Credit Suisse | Downgrade | Outperform → Neutral | — | $856.00 | $774.20 | -9.6% | -18.0% | -17.3% | -20.4% | -18.5% | -15.8% |
No insider trades available.
8-K · 2.02
!! High
American Well Corporation -- 8-K 2.02: Earnings Results
American Well Corporation announced Q1 2026 earnings results, with the company reporting financial performance for the quarter ending March 31, 2026.
May 5
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
I need clarification on the filing content to provide analysis. The summary provided doesn't specify which executive changed roles, their importance, or implications for either AMWL or STT—information essential for assessing stock impact.
Apr 2
8-K
American Well Corporation -- 8-K Filing
American Well Corporation reported its fourth quarter and full year 2025 financial results, providing investors with updated performance metrics for the telehealth services company's recent fiscal period.
Feb 12
Data updated apr 24, 2026 6:02pm
· Source: massive.com